Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  KKR & Co. L.P.    KKR

News SummaryMost relevantAll newsSector newsTweets 

KKR Confirms $3.74 Billion Deal to Buy Gardner Denver

share with twitter share with LinkedIn share with facebook
share via e-mail
03/08/2013 | 02:26am CET

Gardner Denver Inc. (>> Gardner Denver, Inc.) and Kohlberg Kravis Roberts & Co. confirmed the industrial-pumps manufacturer has agreed to be acquired for roughly $3.74 billion.

The New York private-equity firm will pay $76 for each Gardner Denver share, a 2.9% premium to Thursday's close. Shares were recently trading 1.4% higher at $74.91 premarket. The stock has climbed 7.8% since the start of the year.

The deal values Gardner Denver at about $3.9 billion, including the assumption of debt.

KKR had bid $75 a share for the Wayne, Pa.-based company in February and increased the offer after Gardner Denver sought a higher price.

For KKR, the deal would mark the buyout firm's third purchase in the industrials space in the past few years. KKR agreed in April 2011 to acquire Capsugel, a unit of pharmaceutical giant Pfizer Inc. (>> Pfizer Inc.) that makes drugs in capsule form. Later that year, KKR agreed to acquire Capital Safety Inc., a large provider of safety products and equipment for construction and other workers.

KKR ended up being the only serious suitor for Gardner Denver in an up-and-down sales process that dragged on in recent months.

Gardner Denver, which employs about 6,400 people and posted sales of about $2.4 billion last year, pursued a deal with rival SPX Corp. (>> SPX Corporation) late last year after garnering interest from a number of private-equity firms. SPX offered $4 billion for the company but later dropped the bid amid negative reactions from shareholders.

Write to Melodie Warner at melodie.warner@dowjones.com

Order free Annual Report for Gardner Denver Inc.

Visit http://djnewswires.ar.wilink.com/?link=GDI or call 1-888-301-0513

Stocks mentioned in the article : Gardner Denver, Inc., SPX Corporation, Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on KKR & CO. L.P.
03/23 KKR L P : Provident Healthcare Partners Advises Air Medical On Its Acquisition B..
03/23 KKR L P : Completes Tender Offer for Calsonic Kansei
03/23 KKR L P : Announcement Regarding Results of the Tender Offer for the Shares of C..
03/23 KKR L P : Completes Tender Offer for Hitachi Koki
03/23 KKR L P : Announcement Regarding Results of the Tender Offer for the Shares of H..
03/21 KKR & CO. L.P. (NYSE : KKR) Files An 8-K Regulation FD Disclosure
03/21 KKR & CO. L.P. : Regulation FD Disclosure (form 8-K)
03/20 OPTIV SECURITY : Bolsters Northeast Presence with Comm Solutions Acquisition
03/20 KKR & CO. L.P. : Blog Coverage KKR and CDPQ Acquire USI; Set to Strengthen Long-..
03/18 KKR L P : Quebec`s Caisse, KKR team up to acquire USI Insurance Services
More news
Sector news : Investment Management
03/23 Ireland finance ministry appoints bookrunners for AIB IPO
03/23 UBS : set to charge wealthy for keeping euro savings
03/21DJBLACKSTONE LP : Looks to Cash Out of European Warehouse Platform
03/20 HSBC : UBS faces French trial in long-running tax case
03/20 Phoenix Group seeks assets in 300 billion pounds UK pensions market
More sector news : Investment Management
News from SeekingAlpha
03/17 KKR teams with CDPQ to buy USI Insurance
03/16 KKR nears $2B deal for Onex's USI Insurance - WSJ
03/13 AIR METHODS SHORT : Rumors Of A Sale Process Offers An Asymmetric Return Profile
03/06 GNC Stock Rises On Potential KKR Interest
03/06 KKR raises record amount for latest fund
Financials ($)
Sales 2017 1 164 M
EBIT 2017 1 733 M
Net income 2017 144 M
Debt 2017 -
Yield 2017 3,69%
P/E ratio 2017 9,80
P/E ratio 2018 8,28
Capi. / Sales 2017 12,6x
Capi. / Sales 2018 11,8x
Capitalization 14 694 M
More Financials
Chart KKR & CO. L.P.
Duration : Period :
KKR & Co. L.P. Technical Analysis Chart | KKR | US48248M1027 | 4-Traders
Full-screen chart
Technical analysis trends KKR & CO. L.P.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 20,8 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Henry R. Kravis Co-Chairman & Co-Chief Executive Officer
George Rosenberg Roberts Co-Chairman & Co-Chief Executive Officer
William Joseph Janetschek Chief Financial Officer
Joseph A. Grundfest Independent Director
Robert W. Scully Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
KKR & CO. L.P.18.52%14 694
T. ROWE PRICE GROUP IN..-9.38%16 632
AMUNDI S.A.9.30%11 632
More Results